CLINICAL TRIALS PROFILE FOR COVERA-HS

All Clinical Trials for COVERA-HS

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00668967 ↗	Bioequivalence Study Of Verapamil	Completed	Pfizer	Phase 1	2008-02-01	The purpose of this study is to demonstrate bioequivalence of single doses of two verapamil formulations
NCT01607073 ↗	Verapamil as Therapy for Children and Young Adults With Dravet Syndrome	Completed	Ann & Robert H Lurie Children's Hospital of Chicago	Phase 2	2012-04-01	This study will assess how well the drug verapamil can improve control of seizures and dysautonomia symptoms in children and young adults diagnosed with Dravet syndrome. The safety of verapamil when given with all concomitant medications will also be assessed.
NCT01607073 ↗	Verapamil as Therapy for Children and Young Adults With Dravet Syndrome	Completed	Dartmouth-Hitchcock Medical Center	Phase 2	2012-04-01	This study will assess how well the drug verapamil can improve control of seizures and dysautonomia symptoms in children and young adults diagnosed with Dravet syndrome. The safety of verapamil when given with all concomitant medications will also be assessed.
NCT01607073 ↗	Verapamil as Therapy for Children and Young Adults With Dravet Syndrome	Completed	Mayo Clinic	Phase 2	2012-04-01	This study will assess how well the drug verapamil can improve control of seizures and dysautonomia symptoms in children and young adults diagnosed with Dravet syndrome. The safety of verapamil when given with all concomitant medications will also be assessed.
NCT01607073 ↗	Verapamil as Therapy for Children and Young Adults With Dravet Syndrome	Completed	Beverly S. Wical, M.D.	Phase 2	2012-04-01	This study will assess how well the drug verapamil can improve control of seizures and dysautonomia symptoms in children and young adults diagnosed with Dravet syndrome. The safety of verapamil when given with all concomitant medications will also be assessed.
NCT01607073 ↗	Verapamil as Therapy for Children and Young Adults With Dravet Syndrome	Completed	Gillette Children's Specialty Healthcare	Phase 2	2012-04-01	This study will assess how well the drug verapamil can improve control of seizures and dysautonomia symptoms in children and young adults diagnosed with Dravet syndrome. The safety of verapamil when given with all concomitant medications will also be assessed.

Clinical Trial Conditions for COVERA-HS

Condition Name

Condition Name for COVERA-HS
Intervention	Trials
Endoscopic Sinus Surgery	1
FESS	1
Healthy Volunteers	1
Heart Rate	1

Condition MeSH

Condition MeSH for COVERA-HS
Intervention	Trials
Syndrome	1
Epilepsies, Myoclonic	1
Blood Loss, Surgical	1
Hemorrhage	1

Clinical Trial Locations for COVERA-HS

Trials by Country

Trials by Country for COVERA-HS
Location	Trials
United States	4

Trials by US State

Trials by US State for COVERA-HS
Location	Trials
New Hampshire	1
Minnesota	1
Illinois	1
Connecticut	1

Clinical Trial Progress for COVERA-HS

Clinical Trial Phase

Clinical Trial Phase for COVERA-HS
Clinical Trial Phase	Trials
Phase 2	1
Phase 1	1
Early Phase 1	2

Clinical Trial Status

Clinical Trial Status for COVERA-HS
Clinical Trial Phase	Trials
Completed	2
Not yet recruiting	2

Clinical Trial Sponsors for COVERA-HS

Sponsor Name

Sponsor Name for COVERA-HS
Sponsor	Trials
Assiut University	2
Pfizer	1
Ann & Robert H Lurie Children's Hospital of Chicago	1

Sponsor Type

Sponsor Type for COVERA-HS
Sponsor	Trials
Other	7
Industry	1